ArticleCPT: pharmacometrics & systems pharmacology2026
Integrating Population Approaches With Physiologically Based Pharmacokinetic Models: A Novel Framework for Parameter Estimation.
Article in CPT: pharmacometrics & systems pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Best Practices in Physiologically Based Pharmacokinetic (PBPK) Modeling.CPT: pharmacometrics & systems pharmacology · 2026Review
- Integrating Population Approaches With Physiologically Based Pharmacokinetic Models: A Novel Framework for Parameter Estimation.CPT: pharmacometrics & systems pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Physiologically Based Pharmacokinetic (PBPK) modeling is a powerful tool in drug development that integrates drug-specific information with physiological parameters to predict drug concentrations. However, parameter estimation in PBPK models presents significant challenges due to the large number of parameters involved and limited observed data. This tutorial introduces a novel approach coupling whole-body PBPK (WB-PBPK) models with population estimation methods (popWB-PBPK) to leverage individual data and estimate inter-individual variability on physiologically relevant parameters. The framework employs an optimized Stochastic Approximation Expectation-Maximization (SAEM) algorithm, reducing the estimation runtime through an adaptive parameter grid optimization and linear interpolation techniques. Using theophylline as a case study, we illustrate how this approach can accurately estimate drug-specific parameters (CYP1A2 clearance and lipophilicity) while incorporating covariate effects (smoking status). The optimized algorithm significantly reduces computational time compared to the standard SAEM algorithm. Our implementation in the saemixPBPK R package provides an accessible framework for parameter estimation in PBPK models, enabling more robust predictions of pharmacokinetic behavior leveraging individual data. This approach represents an important advancement in mechanistic modeling, allowing simultaneous estimation of population parameters, variability, and uncertainty while maintaining the physiological relevance of PBPK models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.